Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers

Nucleic Acids Research

Volumn 37, Issue 12, 2009, Pages 4135-4148

  Makkonen, Harri ^a   Kauhanen, Miia ^a   Paakinaho, Ville ^a   Jääskeläinen, Tiina ^a   Palvimo, Jorma J ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; BICALUTAMIDE; BRM PROTEIN; CYCLOHEXIMIDE; DACTINOMYCIN; FK 506 BINDING PROTEIN; HISTONE H3; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; PROTEIN FKBP51; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ANDROGEN RESPONSE ELEMENT; ANIMAL CELL; ARTICLE; BINDING SITE; CANCER CELL; CELL STRAIN LNCAP; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; COMPUTER MODEL; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE LOCUS; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRON; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ANDROGEN ANTAGONISTS; ANILIDES; BINDING SITES; CELL LINE, TUMOR; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; INTRONS; MALE; METRIBOLONE; NITRILES; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TACROLIMUS BINDING PROTEINS; TESTOSTERONE CONGENERS; TOSYL COMPOUNDS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 67651180792     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp352     Document Type: Article

References (55)

1. Gao,W., Bohl,C.E. and Dalton,J.T. (2005) Chemistry and structural biology of androgen receptor. Chem. Rev., 105, 3352-3370.
2. Culig,Z., Klocker,H., Bartsch,G. and Hobisch,A. (2002) Androgen receptors in prostate cancer. Endocr. Relat. Cancer, 9, 155-170.
3. Heinlein,C.A. and Chang,C. (2004) Androgen receptor in prostate cancer. Endocr. Rev., 25, 276-308.
4. Kallio,P.J., Poukka,H., Moilanen,A., Jänne,O.A. and Palvimo,J.J. (1995) Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol. Endocrinol., 9, 1017-1028.
5. Palvimo,J.J., Reinikainen,P., Ikonen,T., Kallio,P.J., Moilanen,A. and Jänne,O.A. (1996) Mutual transcriptional interference between RelA and androgen receptor. J. Biol. Chem., 271, 24151-24156.
6. Li,B., Carey,M. and Workman,J.L. (2007) The role of chromatin during transcription. Cell, 128, 707-719.
7. Metivier,R., Gallais,R., Tiffoche,C., Le Peron,C., Jurkowska,R.Z., Carmouche,R.P., Ibberson,D., Barath,P., Demay,F., Reid,G. et al. (2008) Cyclical DNA methylation of a transcriptionally active promoter. Nature, 452, 45-50.
8. Rosenfeld,M.G., Lunyak,V.V. and Glass,C.K. (2006) Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev., 20, 1405-1428.
9. Yamane,K., Toumazou,C., Tsukada,Y., Erdjument-Bromage,H., Tempst,P., Wong,J. and Zhang,Y. (2006) JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell, 125, 483-495.
10. Kouzarides,T. (2007) Chromatin modifications and their function. Cell 128, 693-705.
11. Farrants,A.K. (2008) Chromatin remodelling and actin organisation. FEBS Lett., 582, 2041-2050.
12. Kwon,C.S. and Wagner,D. (2007) Unwinding chromatin for development and growth: A few genes at a time. Trends Genet., 23, 403-412.
13. Racki,L.R. and Narlikar,G.J. (2008) ATP-dependent chromatin remodeling enzymes: Two heads are not better, just different. Curr. Opin. Genet. Dev., 18, 137-144.
14. Trotter,K.W. and Archer,T.K. (2007) Nuclear receptors and chromatin remodeling machinery. Mol. Cell Endocrinol., 265-266, 162-167.
15. Mohrmann,L. and Verrijzer,C.P. (2005) Composition and functional specificity of SWI2/SNF2 class chromatin remodeling complexes. Biochim. Biophys. Acta, 1681, 59-73.
16. Jia,L., Shen,H.C., Wantroba,M., Khalid,O., Liang,G., Wang,Q., Gentzschein,E., Pinski,J.K., Stanczyk,F.Z., Jones,P.A. et al. (2006) Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol. Cell Biol., 26, 7331-7341.
17. Kang,Z., Jänne,O.A. and Palvimo,J.J. (2004) Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol., 18, 2633-2648.
18. Shang,Y., Myers,M. and Brown,M. (2002) Formation of the androgen receptor transcription complex. Mol. Cell, 9, 601-610.
19. Wang,Q., Carroll,J.S. and Brown,M. (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell, 19, 631-642.
20. Wang,Q., Li,W., Liu,X.S., Carroll,J.S., Jänne,O.A., Keeton,E.K., Chinnaiyan,A.M., Pienta,K.J. and Brown,M. (2007) A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell, 27, 380-392.
21. Balk,S.P., Ko,Y.J. and Bubley,G.J. (2003) Biology of prostate-specific antigen. J. Clin. Oncol., 21, 383-391.
22. Mostaghel,E.A., Page,S.T., Lin,D.W., Fazli,L., Coleman,I.M., True,L.D., Knudsen,B., Hess,D.L., Nelson,C.C., Matsumoto,A.M. et al. (2007) Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: Therapeutic implications for castration-resistant prostate cancer. Cancer Res., 67, 5033-5041.
23. Korenchuk,S., Lehr,J.E., MClean,L., Lee,Y.G., Whitney,S., Vessella,R., Lin,D.L. and Pienta,K.J. (2001) VCaP, a cell-based model system of human prostate cancer. In Vivo, 15, 163-168.
24. Thompson,J., Saatcioglu,F., Jänne,O.A. and Palvimo,J.J. (2001) Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity. Mol. Endocrinol., 15, 923-935.
25. Palvimo,J.J., Kallio,P.J., Ikonen,T., Mehto,M. and Jänne,O.A. (1993) Dominant negative regulation of trans-activation by the rat androgen receptor: Roles of the N-terminal domain and heterodimer formation. Mol. Endocrinol., 7, 1399-1407.
26. Makkonen,H., Jaaskelainen,T., Pitkanen-Arsiola,T., Rytinki,M., Waltering,K.K., Matto,M., Visakorpi,T. and Palvimo,J.J. (2008) Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells. Oncogene, 27, 4865-4876.
27. Metivier,R., Penot,G., Hubner,M.R., Reid,G., Brand,H., Kos,M. and Gannon,F. (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell, 115, 751-763.
28. Prescott,J., Jariwala,U., Jia,L., Cogan,J.P., Barski,A., Pregizer,S., Shen,H.C., Arasheben,A., Neilson,J.J., Frenkel,B. et al. (2007) Androgen receptor-mediated repression of novel target genes. Prostate 67, 1371-1383.
29. Shaffer,P.L., Jivan,A., Dollins,D.E., Claessens,F. and Gewirth,D.T. (2004) Structural basis of androgen receptor binding to selective androgen response elements. Proc. Natl Acad. Sci. USA, 101, 4758-4763.
30. Kallio,P.J., Palvimo,J.J., Mehto,M. and Jänne,O.A. (1994) Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. J. Biol. Chem., 269, 11514-11522.
31. Li,B., Howe,L., Anderson,S., Yates,J.R. 3rd. and Workman,J.L. (2003) The Set2 histone methyltransferase functions through the phosphorylated carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem., 278, 8897-8903.
32. Santos-Rosa,H., Schneider,R., Bannister,A.J., Sherriff,J., Bernstein,B.E., Emre,N.C., Schreiber,S.L., Mellor,J. and Kouzarides,T. (2002) Active genes are tri-methylated at K4 of histone H3. Nature 419, 407-411.
33. van Leeuwen,F., Gafken,P.R. and Gottschling,D.E. (2002) Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell, 109, 745-756.
34. Verdone,L., Agricola,E., Caserta,M. and Di Mauro,E. (2006) Histone acetylation in gene regulation. Brief Funct. Genomic Proteomic, 5, 209-221.
35. Chen,C.D., Welsbie,D.S., Tran,C., Baek,S.H., Chen,R., Vessella,R., Rosenfeld,M.G. and Sawyers,C.L. (2004) Molecular determinants of resistance to antiandrogen therapy. Nat. Med., 10, 33-39.
36. Amler,L.C., Agus,D.B., LeDuc,C., Sapinoso,M.L., Fox,W.D., Kern,S., Lee,D., Wang,V., Leysens,M., Higgins,B. et al. (2000) Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res., 60, 6134-6141.
37. Febbo,P.G., Lowenberg,M., Thorner,A.R., Brown,M., Loda,M. and Golub,T.R. (2005) Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer. J. Urol., 173, 1772-1777.
38. Velasco,A.M., Gillis,K.A., Li,Y., Brown,E.L., Sadler,T.M., Achilleos,M., Greenberger,L.M., Frost,P., Bai,W. and Zhang,Y. (2004) Identification and validation of novel androgen-regulated genes in prostate cancer. Endocrinology, 145, 3913-3924.
39. Hubler,T.R. and Scammell,J.G. (2004) Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones, 9, 243-252.
40. Vermeer,H., Hendriks-Stegeman,B.I., van der Burg,B., van Buul-Offers,S.C. and Jansen,M. (2003) Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency, and bioavailability. J. Clin. Endocrinol. Metab., 88, 277-284.
41. Pratt,W.B. and Toft,D.O. (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev., 18, 306-360.
42. Nair,S.C., Rimerman,R.A., Toran,E.J., Chen,S., Prapapanich,V., Butts,R.N. and Smith,D.F. (1997) Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol. Cell Biol., 17, 594-603.
43. Smith,D.F., Faber,L.E. and Toft,D.O. (1990) Purification of unactivated progesterone receptor and identification of novel receptor-associated proteins. J. Biol. Chem., 265, 3996-4003.
44. Magee,J.A., Chang,L.W., Stormo,G.D. and Milbrandt,J. (2006) Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology, 147, 590-598.
45. Claessens,F., Verrijdt,G., Schoenmakers,E., Haelens,A., Peeters,B., Verhoeven,G. and Rombauts,W. (2001) Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J. Steroid Biochem. Mol. Biol., 76, 23-30.
46. Magklara,A. and Smith,C.L. (2009) A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2. Mol. Endocrinol., 23, 61-73.
47. Lupien,M., Eeckhoute,J., Meyer,C.A., Wang,Q., Zhang,Y., Li,W., Carroll,J.S., Liu,X.S. and Brown,M. (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958-970.
48. Link,K.A., Balasubramaniam,S., Sharma,A., Comstock,C.E., Godoy-Tundidor,S., Powers,N., Cao,K.H., Haelens,A., Claessens,F., Revelo,M.P. et al. (2008) Targeting the BAF57 SWI/SNF subunit in prostate cancer: A novel platform to control androgen receptor activity. Cancer Res., 68, 4551-4558.
49. Marshall,T.W., Link,K.A., Petre-Draviam,C.E. and Knudsen,K.E. (2003) Differential requirement of SWI/SNF for androgen receptor activity. J. Biol. Chem., 278, 30605-30613.
50. Wang,Q., Sharma,D., Ren,Y. and Fondell,J.D. (2002) A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. J. Biol. Chem., 277, 42852-42858.
51. Vijayvargia,R., May,M.S. and Fondell,J.D. (2007) A coregulatory role for the mediator complex in prostate cancer cell proliferation and gene expression. Cancer Res., 67, 4034-4041.
52. Carroll,J.S., Meyer,C.A., Song,J., Li,W., Geistlinger,T.R., Eeckhoute,J., Brodsky,A.S., Keeton,E.K., Fertuck,K.C., Hall,G.F. et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat. Genet., 38, 1289-1297.
53. Bolton,E.C., So,A.Y., Chaivorapol,C., Haqq,C.M., Li,H. and Yamamoto,K.R. (2007) Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev., 21, 2005-2017.
54. Fraser,P. and Bickmore,W. (2007) Nuclear organization of the genome and the potential for gene regulation. Nature, 447, 413-417.
55. Morris,D.S., Tomlins,S.A., Montie,J.E. and Chinnaiyan,A.M. (2008) The discovery and application of gene fusions in prostate cancer. BJU Int., 102, 276-282.